RENDON EUROPE LABORATORIES SL

What RENDON EUROPE LABORATORIES SL does

RENDON EUROPE LABORATORIES SL is a privately held Spanish Sociedad Limitada founded in 2014 and headquartered in Madrid (C. de Angelita Camarero, 9F, 28035). The company develops and commercializes medical devices and foods for special medical purposes focused on rare diseases, principally cystic fibrosis, phenylketonuria (PKU), and amino acid innate metabolism errors, with an emphasis on pediatric patients. Its product portfolio spans two brand families: RELAIR, a line of anti-static inhalation spacer chambers available in three age-segmented variants (Baby 0-3 years, Junior 3-12 years, Senior 12+ years) with interchangeable hypoallergenic silicone masks and a patent-pending unique ID marking system intended to prevent cross-infection between users; and the AUMES line of specialized nutrition products including PKU GOLIKE for phenylketonuria and FIADEK and BiDHA formulations in capsule and liquid forms for cystic fibrosis-related malabsorption and pancreatic insufficiency.

Commercially, Rendon Europe operates a direct-to-consumer e-commerce storefront at rendonlab.es, accepting Visa and MasterCard payments with 48-72 hour delivery to the Spanish Peninsula and Balearic Islands, and reaches healthcare professionals (pulmonologists, gastroenterologists, pediatricians, dietitians) through medical-specialty contact forms and newsletter communications. AUMES nutritional products are dispensed under medical supervision, creating a gated-access revenue stream distinct from direct cash-pay RELAIR device sales (priced at 33.88-34.97 EUR including VAT for the Baby and Senior variants). The company maintains an active social media presence across Facebook, LinkedIn, X, and Instagram and complies with EU Regulation 2017/745 for medical devices and 2017/746 for in vitro diagnostics. With approximately 5 employees and no external funding, M&A activity, or disclosed leadership hires on record, the business operates as a lean, owner-managed distribution and commercialization platform for its licensed/developed medical device and nutrition portfolio within the Spanish market.

Name

RENDON EUROPE LABORATORIES SL

Legal name

RENDON EUROPE LABORATORIES, SL

Website

https://rendonlab.es

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

RENDON EUROPE LABORATORIES SL is a Madrid-based Spanish private company that develops and sells medical devices (RELAIR anti-static inhalation chambers) and specialized nutritional products (AUMES line for PKU and cystic fibrosis) targeting rare-disease and pediatric patients in Spain via direct e-commerce and healthcare professional channels.

Ownership category

akta.pro rank

Product category

Medical Devices and Specialized Nutritional Products

NAICS

Medical Equipment and Supplies Manufacturing (3391), Surgical and Medical Instrument Manufacturing (339112), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834)

akta.pro primary industry

Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories) (HLAHAGAE)

akta.pro secondary industry

Pulmonary Hypertension & Rare Pulmonary Disease Therapies (HLAIAIAG)

Keywords

• Medical devices
• Respiratory therapy products
• Specialized medical nutrition
• Inhalation spacer chambers
• Rare disease treatments

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D

Revenue model

1. Medical Device Sales: Sale of RELAIR anti-static inhalation chambers and accessories (masks, mouthpieces) directly to patients and healthcare facilities in Spain. Products sold at unit prices (33.88-34.97 EUR including VAT) through e-commerce.
2. Specialized Medical Nutrition Products: Sale of foods for special medical uses including PKU GOLIKE for Phenylketonuria, FIADEK vitamins for cystic fibrosis malabsorption, and BiDHA supplements for cystic fibrosis and pancreatic insufficiency. Products distributed under medical supervision.
3. Healthcare Professional Communications: Company collects contact data from healthcare professionals for sending newsletters, commercial offers and product information communications.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

RENDON EUROPE LABORATORIES SL develops and commercializes proprietary medical devices and specialized foods for special medical purposes targeted at rare disease patients in Spain. The portfolio centers on the RELAIR® line of anti-static inhalation spacer chambers (Baby, Junior, Senior variants) for efficient administration of metered-dose inhaler medications, and the AUMES line including PKU GOLIKE® (phenylketonuria), FIADEK® (fat-soluble vitamins for cystic fibrosis malabsorption), and BiDHA® (DHA supplements). All medical devices are regulated under EU MDR 2017/745 and IVDR 2017/746.

Product overview

RENDON EUROPE LABORATORIES SL offers a portfolio of medical devices and specialized nutritional products focused on rare diseases, particularly cystic fibrosis and amino acid metabolism disorders. The product portfolio comprises two main lines: RELAIR® antistatic inhalation spacer chambers (available in Baby, Junior, and Senior variants for different age groups) designed for efficient administration of inhaled medications via MDI inhalers, and the AUMES line of foods for special medical purposes including PKU GOLIKE® for phenylketonuria management, FIADEK® (fat-soluble vitamins with antioxidants in capsules and liquid form), and BiDHA® (DHA supplements in capsules and liquid form) for cystic fibrosis and pancreatic insufficiency nutritional support.

Differentiator

Problem solved

Functional benefit

Brands

• RELAIR: Antiestatic inhalation chamber for administering inhaled medications, available in Baby, Junior, and Senior variants for different age groups.
• AUMES
• PKU GOLIKE
• FIADEK
• BiDHA

Products and services

• RELAIR® Baby Antistatic inhalation spacer chamber with anti-allergic silicone mask designed for infants aged 0-3 years, featuring unique ID marking system for individual use to prevent cross-contamination. Priced at 33.88 EUR including VAT.
• RELAIR® Junior Antistatic inhalation spacer chamber for children aged 3-12 years, designed for safe and efficient administration of most MDI (metered-dose inhaler) medications. Price available on request.
• RELAIR® Senior Antistatic inhalation spacer chamber with anti-allergic silicone mask for patients 12 years and older, featuring universal base, audible alarm whistle for incorrect breathing, unidirectional valve with flow indicator, and patent-pending unique ID system for individual patient use. Priced at 34.97 EUR including VAT.
• PKU GOLIKE® Food for special medical purposes with formulations tailored for patients with Phenylketonuria (PKU) across different age groups, designed to optimize metabolic management and treatment compliance.
• FIADEK® Cápsulas Fat-soluble vitamins with Vitamin C, E, Zinc and antioxidants in capsule form for dietary management of cystic fibrosis and conditions involving malabsorption of vitamins and nutrients.
• FIADEK® Líquido Fat-soluble vitamins in liquid form for dietary management of cystic fibrosis and conditions involving malabsorption of fat-soluble vitamins and antioxidants.
• BiDHA® Cápsulas Docosahexaenoic acid (DHA) supplement in capsule form for nutritional management of cystic fibrosis, exocrine pancreatic insufficiency, and conditions requiring extra DHA intake.
• BiDHA® Líquido Liquid DHA supplement for nutritional management of cystic fibrosis, exocrine pancreatic insufficiency, and clinical situations requiring additional DHA supplementation.

Quantifiable outcome

• RELAIR chambers support minimum 100 hygiene/disinfection or sterilization cycles without losing functionality
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Clement Clarke International: UK-based maker of the Able Spacer and related respiratory drug delivery devices, a direct competitor in the anti-static spacer chamber category targeted at asthma, COPD, and pediatric respiratory patients.
• PARI Medical Holding: Global manufacturer of nebulizers, spacers, and inhalation drug delivery systems, particularly active in cystic fibrosis and severe respiratory disease — directly comparable to Rendon Europe's RELAIR and AUMES CF product lines.
• Medical Device International (MDI): Manufacturer of various spacer chamber brands distributed across European and international markets, directly comparable to Rendon's RELAIR anti-static inhalation chamber business.
• Trudell Medical International: Manufacturer of the AeroChamber brand of anti-static valved holding chambers (spacers) for MDIs, the most established direct competitor to Rendon Europe's RELAIR line in pediatric and adult respiratory care.

Broad incumbents

• Philips Respironics: Broad respiratory and sleep therapy incumbent with portfolio overlap in spacers, nebulizers, and inhalation drug delivery; serves as a large competitor with much deeper distribution into hospitals and homecare channels.
• VitalAire (Air Liquide Healthcare): European home respiratory care provider with extensive distribution of inhalation devices, nebulizers, and respiratory accessories — directly comparable distribution channel to Rendon's Spain-focused respiratory business.
• Nutricia (Danone Specialized Nutrition): Major manufacturer of medical foods for PKU and other inborn errors of metabolism (e.g., Anamix, Lophlex), directly comparable to Rendon's AUMES/PKU GOLIKE portfolio and a leading incumbent in rare metabolic disease nutrition.
• Chiesi Farmaceutici: Specialty pharmaceutical company with significant presence in cystic fibrosis and rare respiratory diseases in Europe; overlapping therapeutic focus with Rendon's CF products and broader respiratory franchise.
• Nestlé Health Science: Global medical nutrition player with PKU and metabolic disorder product lines comparable to Rendon's PKU GOLIKE and broader AUMES portfolio, with much deeper distribution and clinical evidence infrastructure.
• Abbott Nutrition (Metabolic Division): Major medical nutrition manufacturer with established PKU and metabolic disorder product lines, overlapping with Rendon's AUMES metabolic nutrition portfolio across EU markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/RendonEuropeLab
• Facebookfacebook.com/RendonEurope
• LinkedInlinkedin.com/company/rendon-europe-laboratories
• Instagraminstagram.com/rendoneuropelaboratories/?hl=es

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RENDON EUROPE LABORATORIES SL